Richard Rudick
Board Member
Immunic, Inc. (IMUX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Richard Rudick
Richard Rudick is recorded as Board Member at Immunic, Inc. (IMUX). Immunic, Inc. reported in an 8-K filed June 29, 2026 that Richard Rudick was appointed Class III Director, effective June 29, 2026. Immunic, Inc. reported in an 8-K filed April 27, 2023 that Richard Rudick was appointed member of the Board of Directors, effective April 26, 2023.
“to elect Mr. Michael Bonney, Mr. Thorvald Nagel and Dr. Richard Rudick as Class III Directors to serve until our 2029 annual meeting of stockholders and until their successors are duly elected and qualified”
“On April 27, 2023, Immunic, Inc. (the “Company”) announced the appointment of Dr. Richard Rudick as a member of the Board of Directors (the “Board”) of the Company, effective as of April 26, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-06-29–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Immunic, Inc.
Other people whose current roles at this company are on record from its filings.
- Dr. Daniel Vitt CEO
- Duane D. Nash CEO
- Duane Nash CEO
- Erik Lundgren CEO, Board Member
- Russell J. Cox CEO
- Michael W. Bonney Chairman
- Simona Skerjanec Chairman, Board Member
- Glenn Whaley CFO
- Jason Tardio COO
- Inderpal Singh General Counsel
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.